Download PDF
CC BY-NC-ND 4.0 · Indian J Plast Surg 2023; 56(02): 124-129
DOI: 10.1055/s-0042-1760251
Original Article

Craniofacial Fibrous Dysplasia: Surgical Management and Long-Term Outcomes at a Referral Center in Mexico City

Luis Alejandro Lopez-Garibay
1   Plastic and Reconstructive Surgery Division, Hospital General “Dr Manuel Gea Gonzalez” Postgraduate Division of the Medical School, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico
,
Osvaldo Guevara-Valmaña
1   Plastic and Reconstructive Surgery Division, Hospital General “Dr Manuel Gea Gonzalez” Postgraduate Division of the Medical School, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico
,
Jose Eduardo Telich-Tarriba 
1   Plastic and Reconstructive Surgery Division, Hospital General “Dr Manuel Gea Gonzalez” Postgraduate Division of the Medical School, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico
,
David Felipe Navarro-Barquín
1   Plastic and Reconstructive Surgery Division, Hospital General “Dr Manuel Gea Gonzalez” Postgraduate Division of the Medical School, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico
,
Natalia Haro-Alvarez
1   Plastic and Reconstructive Surgery Division, Hospital General “Dr Manuel Gea Gonzalez” Postgraduate Division of the Medical School, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico
,
Laura Andrade-Delgado 
1   Plastic and Reconstructive Surgery Division, Hospital General “Dr Manuel Gea Gonzalez” Postgraduate Division of the Medical School, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico
,
Rogelio Martínez-Wagner
1   Plastic and Reconstructive Surgery Division, Hospital General “Dr Manuel Gea Gonzalez” Postgraduate Division of the Medical School, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Background Craniofacial fibrous dysplasia (CFD) is an uncommon benign condition in which a bone is replaced by fibrous tissue. An adequate clinical characterization considering the number of affected bones and functional impairment is important to determine the most effective surgical intervention for its management. This study aims to present our institution's experience in the evaluation and management of CFD.

Methods This was a retrospective study that included patients with CFD managed at our institution. Data included demographic characteristics, afflicted bones, surgical procedures performed, and recurrence. Results are presented as mean and percentages. Recurrence-free years and association between the type of surgery and recurrence was evaluated.

Results Eighteen patients were included (11 females, 61%). The zygomatic, maxillary, and frontal bones were the most commonly affected with eight (18%) cases each. The most common procedure was bone burring, with 36 procedures. Recurrence was more prevalent after burring (58.3%) and occurred earlier than in the bone resection group (13 vs. 15 years, p > 0.05).

Conclusion Surgery continues to be the cornerstone of CFD treatment. Bone burring is effective for debulking and contouring but increases the risk for recurrence. An individualized approach should be tailored according to the anatomical location of the disease, type of CFD, behavior of the lesion, and accompanying clinical complaints.

Keywords

fibrous dysplasia - polyostotic - craniofacial fibrous dysplasia - mandibular osteotomy - follow-up studies - recurrence - GTP-binding proteins

Ethical Statement

This study was approved by our institutional ethics committee.




Publication History

Article published online:
13 March 2023

© 2023. Association of Plastic Surgeons of India. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Ricalde P, Magliocca KR, Lee JS. Craniofacial fibrous dysplasia. Oral Maxillofac Surg Clin North Am 2012; 24 (03) 427-441
    CrossrefPubMedGoogle Scholar
  • 2 Lichtenstein L. Polyostotic fibrous dysplasia. Arch Surg 1938; 36 (05) 874-898 DOI: 10.1001/archsurg.1938.01190230153012.
    CrossrefGoogle Scholar
  • 3 Weinstein LS, Chen M, Liu J. Gs(alpha) mutations and imprinting defects in human disease. Ann N Y Acad Sci 2002; 968: 173-197
    CrossrefPubMedGoogle Scholar
  • 4 Florez H, Peris P, Guañabens N. Fibrous dysplasia. Clinical review and therapeutic management. Med Clin (Barc) 2016; 147 (12) 547-553
    PubMedGoogle Scholar
  • 5 Shenker A, Weinstein LS, Sweet DE, Spiegel AM. An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome. J Clin Endocrinol Metab 1994; 79 (03) 750-755
    PubMedGoogle Scholar
  • 6 Lloyd T, Berridge NL. Fibrous dysplasia. In: Brennan PA, Schliephake H, Ghali GE, Cascarini L. Maxillofacial Surgery, 3rd ed, Churchill Livingstone; 2017: 1358-1367
    Google Scholar
  • 7 Katz BJ, Nerad JA. Ophthalmic manifestations of fibrous dysplasia: a disease of children and adults. Ophthalmology 1998; 105 (12) 2207-2215
    CrossrefPubMedGoogle Scholar
  • 8 Burke AB, Collins MT, Boyce AM. Fibrous dysplasia of bone: craniofacial and dental implications. Oral Dis 2017; 23 (06) 697-708
    CrossrefPubMedGoogle Scholar
  • 9 Boyce AM, Burke A, Cutler Peck C, DuFresne CR, Lee JS, Collins MT. Surgical management of polyostotic craniofacial fibrous dysplasia: long-term outcomes and predictors for postoperative regrowth. Plast Reconstr Surg 2016; 137 (06) 1833-1839
    CrossrefPubMedGoogle Scholar
  • 10 Rahman AM, Madge SN, Billing K. et al. Craniofacial fibrous dysplasia: clinical characteristics and long-term outcomes. Eye (Lond) 2009; 23 (12) 2175-2181
    CrossrefPubMedGoogle Scholar
  • 11 Wu H, Yang L, Li S. et al. Clinical characteristics of craniomaxillofacial fibrous dysplasia. J Craniomaxillofac Surg 2014; 42 (07) 1450-1455
    CrossrefPubMedGoogle Scholar
  • 12 Yang L, Wu H, Lu J, Teng L. Prevalence of different forms and involved bones of craniofacial fibrous dysplasia. J Craniofac Surg 2017; 28 (01) 21-25
    CrossrefPubMedGoogle Scholar
  • 13 Lee JS, FitzGibbon EJ, Chen YR. et al. Clinical guidelines for the management of craniofacial fibrous dysplasia. Orphanet J Rare Dis 2012; 7 (Suppl. 01) S2
    CrossrefPubMedGoogle Scholar
  • 14 Javaid MK, Boyce A, Appelman-Dijkstra N. et al. Best practice management guidelines for fibrous dysplasia/McCune-Albright syndrome: a consensus statement from the FD/MAS international consortium. Orphanet J Rare Dis 2019; 14 (01) 139
    CrossrefPubMedGoogle Scholar
  • 15 Gabbay JS, Yuan JT, Andrews BT, Kawamoto HK, Bradley JP. Fibrous dysplasia of the zygomaticomaxillary region: outcomes of surgical intervention. Plast Reconstr Surg 2013; 131 (06) 1329-1338
    CrossrefPubMedGoogle Scholar
  • 16 Valentini V, Cassoni A, Marianetti TM, Terenzi V, Fadda MT, Iannetti G. Craniomaxillofacial fibrous dysplasia: conservative treatment or radical surgery? A retrospective study on 68 patients. Plast Reconstr Surg 2009; 123 (02) 653-660
    CrossrefPubMedGoogle Scholar
  • 17 Denadai R, Raposo-Amaral CA, Raposo-Amaral CE. Fat grafting in managing craniofacial deformities. Plast Reconstr Surg 2019; 143 (05) 1447-1455
    CrossrefPubMedGoogle Scholar
  • 18 Yeow VK, Chen YR. Orthognathic surgery in craniomaxillofacial fibrous dysplasia. J Craniofac Surg 1999; 10 (02) 155-159
    CrossrefPubMedGoogle Scholar
  • 19 Florenzano P, Pan KS, Brown SM. et al. Age-related changes and effects of bisphosphonates on bone turnover and disease progression in fibrous dysplasia of bone. J Bone Miner Res 2019; 34 (04) 653-660
    CrossrefPubMedGoogle Scholar